Michelle Zupa

Michelle Zupa

Auto-generated profile, based on publicly available information

Michelle Zupa

Yale School of Public Health , New Haven, CT

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Journal of Clinical Oncology
Verified
Journal Article
Open access
TSTara Sanft
Tara Sanft
MHMaura Harrigan
Maura Harrigan
CMCourtney McGowan
Courtney McGowan
BCBrenda Cartmel
Brenda Cartmel
MZMichelle Zupa
Michelle Zupa
MIMelinda L. Irwin
Melinda L. Irwin
PURPOSE: Successful completion of chemotherapy is critical to improve breast cancer outcomes. Relative dose intensity (RDI), defined as the ratio of chemotherapy delivered to prescribed, is a measure of chemotherapy completion and is associated with cancer mortality. The effect of exercise and eating a healthy diet on RDI is unknown. We conducted a randomized trial of an exercise and nutrition intervention on RDI and pathologic complete response (pCR) in women diagnosed with breast cancer initiating chemotherapy. METHODS: One hundred seventy-three women with stage I-III breast cancer were randomly assigned to usual care (UC; n = 86) or a home-based exercise and nutrition intervention with counseling sessions delivered by oncology-certified registered dietitians (n = 87). Chemotherapy dose adjustments and delays and pCR were abstracted from electronic medical records. T-tests and chi-square tests were used to examine the effect of the intervention versus UC on RDI and pCR. RESULTS: Participants randomly assigned to intervention had greater improvements in exercise and diet quality compared with UC ( P < .05). RDI was 92.9% ± 12.1% and 93.6% ± 11.1% for intervention and UC, respectively ( P = .69); the proportion of patients in the intervention versus UC who achieved ≥85% RDI was 81% and 85%, respectively ( P = .44). The proportion of patients who had at least one dose reduction and/or delay was 38% intervention and 36% UC ( P = .80). Among 72 women who received neoadjuvant chemotherapy, women randomly assigned to intervention were more likely to have a pCR than those randomly assigned to UC (53% v 28%; P = .037). CONCLUSION: Although a diet and exercise intervention did not affect RDI, the intervention was associated with a higher pCR in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative and triple-negative breast cancer undergoing neoadjuvant chemotherapy.


26 December 2025 in JNCI Cancer Spectrum
Verified
Journal Article
Open access
LPLeah Puklin
Leah Puklin
FLFangyong Li
Fangyong Li
LFLeah Ferrucci
Leah Ferrucci
BCBrenda Cartmel
Brenda Cartmel
MHMaura Harrigan
Maura Harrigan
MIMelinda L. Irwin
Melinda L. Irwin
Background: Chemotherapy-induced side effects can diminish physical and psychological well-being for women with breast cancer. Although nutrition and exercise improve quality of life (QoL) posttreatment, their ability to attenuate treatment-related declines in QoL during chemotherapy remains underexplored. Methods: Women diagnosed with stage I-III breast cancer initiating chemotherapy were randomized to a yearlong nutrition and exercise intervention (I; n = 87) or usual care (UC; n = 86). Patient-Reported Outcomes Measurement Information System (PROMIS)-29, PROMIS Cognitive Function, and PROMIS Global Health scales were assessed at diagnosis (baseline), postchemotherapy (PC), 1-year, and 2-years postrandomization. Results: Participants (N = 173) were on average 52.8 ± 11.1 years of age and 51% had stage I breast cancer. At diagnosis, PROMIS scores were comparable to the general US population, except for heightened anxiety. PROMIS scores worsened from diagnosis to PC for physical function (I = −5.5 (1.0); UC = −5.4 (1.0)), fatigue (I = 5.4 (1.1); UC = 6.2 (1.1)), social roles (I = −5.4 (1.0); UC = −7.1 (1.0)), cognitive function (I = −4.8 (1.0); UC = −4.3 (1.1)), global physical health (I = −10.9 (0.8); UC = −10.1 (0.8)), and global mental health (I = −11.2 (1.1); UC = −9.7 (1.2)), with anxiety improving (I = −5.1 (0.9); UC = −3.7 (0.9)). No between-arm differences were observed. By 1 year, most scores returned to baseline levels and remained stable through 2 years, except anxiety, which remained improved. Conclusion: Despite improving nutrition and exercise, the intervention did not attenuate declines in QoL compared with UC. This study fills a gap on interventions with nutrition and exercise components during chemotherapy and highlights needing more research to identify those most likely to have benefits in QoL from lifestyle interventions delivered during active treatment. Clinical Trial Registration: NCT03314688

2 December 2025 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
JRJamie M Reedy
Jamie M Reedy
NBNancy A. Borstelmann
Nancy A. Borstelmann
SSSakinah Suttiratana
Sakinah Suttiratana
TSThejal Srikumar
Thejal Srikumar
FFFarah Fasihuddin
Farah Fasihuddin
VGVeda N. Giri
Veda N. Giri
Purpose: Early onset cancers (EOC), defined as cancers diagnosed between the ages of 18 and 49, are on the rise. Younger adults may experience amplified cancer-related challenges. Furthermore, the unique needs of Black/African American (B/AA) and Hispanic/Latine (H/L) adults with EOC have been understudied. Here we report on results from the PROSPER study, which explored the experiences of B/AA and H/L patients with EOC. Methods: Patients diagnosed with early onset breast, gastrointestinal (GI), genitourinary, and gynecological cancers were recruited from a single institution in the Northeastern US. Between February 2024 and April 2024, data were collected from 14 women who participated in both individual interviews (B/AA = 7; H/L = 7) and focus groups (B/AA Group, n = 5; H/L Group, n = 3) in English and/or Spanish. Participants (ages 28–49) were diagnosed with breast ( n = 7), GI ( n = 5), ovarian ( n = 1), or breast and GI ( n = 1) cancer. Interviews were recorded, transcribed, and qualitatively analyzed using modified rapid analysis techniques. Results: Thematic analysis identified challenges across six psychosocial domains spanning the impact of cancer on the patient and family, limited access to information, communication concerns, financial strain, and balancing care with life activities. We also identified unique barriers within our cohort related to clinical care, support needs, and applicable research. Conclusion: Our results support existing literature on the challenges faced by patients with EOCs, while also providing critical insights into the unique experiences of B/AA and H/L women with EOCs. These results inform the development of EOC program strategies.